Immunitybio Inc (IBRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -354,466 | -268,714 | -134,130 | -583,852 | -350,438 |
| Depreciation Amortization | 30,996 | 20,342 | 9,613 | 61,794 | 49,210 |
| Accounts receivable | -4,175 | -1,033 | 0 | N/A | N/A |
| Accounts payable and accrued liabilities | 47 | 8,969 | 4,314 | -6,476 | -3,599 |
| Other Working Capital | -8,580 | 1,470 | -3,893 | 3,828 | 29,726 |
| Other Operating Activity | 30,086 | 31,637 | 17,114 | 157,949 | 23,615 |
| Operating Cash Flow | $-306,092 | $-207,329 | $-106,982 | $-366,757 | $-251,486 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -134,129 | -134,129 | -48,363 | -10,358 | -10,192 |
| PPE Investments | -4,777 | -1,985 | -1,261 | -30,584 | -22,629 |
| Net Acquisitions | -1,000 | N/A | N/A | N/A | N/A |
| Sale Of Investment | 118,573 | 49,002 | 14,002 | 10,472 | 102 |
| Other Investing Activity | -747 | 0 | 0 | 0 | 0 |
| Investing Cash Flow | $-22,080 | $-87,112 | $-35,622 | $-30,470 | $-32,719 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | 258,700 | 258,700 |
| Debt Repayment | -64 | -42 | -21 | -77 | -57 |
| Common Stock Issued | 82,471 | 66,568 | 14,116 | 110,397 | 101,040 |
| Other Financing Activity | 92,294 | 92,593 | -3,870 | 189,321 | -1,881 |
| Financing Cash Flow | $174,701 | $159,119 | $10,225 | $558,341 | $357,802 |
| Exchange Rate Effect | -16 | -27 | -39 | -292 | -265 |
| Beginning Cash Position | 265,787 | 265,787 | 265,787 | 104,965 | 104,965 |
| End Cash Position | 112,300 | 130,438 | 133,369 | 265,787 | 178,297 |
| Net Cash Flow | $-153,487 | $-135,349 | $-132,418 | $160,822 | $73,332 |
| Free Cash Flow | |||||
| Operating Cash Flow | -306,092 | -207,329 | -106,982 | -366,757 | -251,486 |
| Capital Expenditure | -4,777 | -1,985 | -1,261 | -30,584 | -22,629 |
| Free Cash Flow | -310,869 | -209,314 | -108,243 | -397,341 | -274,115 |